SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
PDILT | Protein disulfide isomerase-like, testis expressed | Predicted secreted proteins
| | | | | Group enriched |
NKX6-2 | NK6 homeobox 2 | Transcription factors
| | | | | Group enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |
TFF2 | Trefoil factor 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
NKX6-3 | NK6 homeobox 3 | Transcription factors
| | | | | Group enriched |
SLC9A4 | Solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CFC1 | Cripto, FRL-1, cryptic family 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
CHIA | Chitinase, acidic | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CFC1B | Cripto, FRL-1, cryptic family 1B | Predicted secreted proteins
| | | | | Group enriched |
FAM159B | Family with sequence similarity 159, member B | Predicted membrane proteins
| | | | | Group enriched |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Group enriched |
VSIG1 | V-set and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
REP15 | RAB15 effector protein | | | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GCKR | Glucokinase (hexokinase 4) regulator | | | | | | Group enriched |
PSAPL1 | Prosaposin-like 1 (gene/pseudogene) | Predicted secreted proteins
| | | | | Group enriched |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets
| | | | | Group enriched |
AMTN | Amelotin | Predicted secreted proteins
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
FUT9 | Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) | Predicted membrane proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
NTS | Neurotensin | Predicted secreted proteins
| | | | | Group enriched |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
EPS8L3 | EPS8-like 3 | | | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KPNA7 | Karyopherin alpha 7 (importin alpha 8) | | | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
C2orf70 | Chromosome 2 open reading frame 70 | | | | | | Group enriched |
CELF3 | CUGBP, Elav-like family member 3 | | | | | | Group enriched |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FSIP2 | Fibrous sheath interacting protein 2 | | | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
MIA | Melanoma inhibitory activity | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | | | Group enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
BCL2L15 | BCL2-like 15 | | | | | | Group enriched |